Vicken Karageozian
Fondatore presso Allegro Ophthalmics LLC
Posizioni attive di Vicken Karageozian
Società | Posizione | Inizio | Fine |
---|---|---|---|
University of California, Irvine | Corporate Officer/Principal | - | - |
Allegro Ophthalmics LLC
Allegro Ophthalmics LLC BiotechnologyHealth Technology Allegro Ophthalmics LLC operates as a biopharmaceutical company. It focuses on the development of novel integrin-regulating therapies for the treatment of ocular diseases. The company was founded by Hampar Karageozian and John Park and is headquartered in San Juan Capistrano, CA. | Direttore/Membro del Consiglio | - | - |
Amministratore Delegato | 01/08/2018 | - | |
Fondatore | 01/01/1993 | - | |
Presidente | 15/03/2016 | - | |
Direttore Tecnico/Scientifico/R&S | - | - |
Storia della carriera di Vicken Karageozian
Precedenti posizioni note di Vicken Karageozian
Società | Posizione | Inizio | Fine |
---|---|---|---|
Allergan Pharmaceuticals Ltd., Inc.
Allergan Pharmaceuticals Ltd., Inc. Pharmaceuticals: MajorHealth Technology Allergan Pharmaceuticals Ltd., Inc. develops and distributes pharmaceuticals, biologics and medical devices. It imports and exports pharmaceutical products. The company is located in Irvine, CA | Corporate Officer/Principal | - | - |
ISTA Pharmaceuticals, Inc.
ISTA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology ISTA Pharmaceuticals, Inc. was incorporated as Advanced Corneal Systems, Inc. in California in February 1992 to discover, develop, and market new remedies for diseases and conditions of the eye. In March 2000, the company changed its name to ISTA Pharmaceuticals, Inc. It reincorporated, in Delaware, in August 2000. BROMDAY, BEPREVE, ISTALOL, VITRASE, XIBROM (bromfenac ophthalmic solution), XIBROM, T-PRED, PROLENSA, BEPOSONE, BEPOMAX, ISTA, ISTA Pharmaceuticals, Inc. and the ISTA logo are its trademarks, either owned or under license. Ista is commercial-stage, multi-specialty pharmaceutical company, which develops, markets, and sells its own products in the United States and Puerto Rico. Its products are intended to treat allergy and serious diseases of the eye and include therapies for ocular inflammation and pain, glaucoma, dry eye, and ocular and nasal allergies. | Corporate Officer/Principal | - | - |
VitreoRetinal Technologies, Inc.
VitreoRetinal Technologies, Inc. Medical SpecialtiesHealth Technology Vitreoretinal Technologies, Inc. was a pharmaceutical company. It was used to develop and commercialize innovative therapeutic systems for the treatment of serious ocular diseases. The company was founded in July 1999 and was headquartered in Irvine, CA. | Presidente | 01/07/1999 | 07/08/2009 |
Direttore Tecnico/Scientifico/R&S | 01/07/1999 | - | |
Fondatore | 20/07/2009 | - | |
Vendite & Marketing | 10/08/2009 | - |
Formazione di Vicken Karageozian
Tufts University | Doctorate Degree |
University of California San Diego | Undergraduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 8 |
Posizioni
Corporate Officer/Principal | 3 |
Chief Tech/Sci/R&D Officer | 2 |
Founder | 2 |
Settori
Health Technology | 5 |
Consumer Services | 4 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 4 |
---|---|
VitreoRetinal Technologies, Inc.
VitreoRetinal Technologies, Inc. Medical SpecialtiesHealth Technology Vitreoretinal Technologies, Inc. was a pharmaceutical company. It was used to develop and commercialize innovative therapeutic systems for the treatment of serious ocular diseases. The company was founded in July 1999 and was headquartered in Irvine, CA. | Health Technology |
Allergan Pharmaceuticals Ltd., Inc.
Allergan Pharmaceuticals Ltd., Inc. Pharmaceuticals: MajorHealth Technology Allergan Pharmaceuticals Ltd., Inc. develops and distributes pharmaceuticals, biologics and medical devices. It imports and exports pharmaceutical products. The company is located in Irvine, CA | Health Technology |
ISTA Pharmaceuticals, Inc.
ISTA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology ISTA Pharmaceuticals, Inc. was incorporated as Advanced Corneal Systems, Inc. in California in February 1992 to discover, develop, and market new remedies for diseases and conditions of the eye. In March 2000, the company changed its name to ISTA Pharmaceuticals, Inc. It reincorporated, in Delaware, in August 2000. BROMDAY, BEPREVE, ISTALOL, VITRASE, XIBROM (bromfenac ophthalmic solution), XIBROM, T-PRED, PROLENSA, BEPOSONE, BEPOMAX, ISTA, ISTA Pharmaceuticals, Inc. and the ISTA logo are its trademarks, either owned or under license. Ista is commercial-stage, multi-specialty pharmaceutical company, which develops, markets, and sells its own products in the United States and Puerto Rico. Its products are intended to treat allergy and serious diseases of the eye and include therapies for ocular inflammation and pain, glaucoma, dry eye, and ocular and nasal allergies. | Health Technology |
Allegro Ophthalmics LLC
Allegro Ophthalmics LLC BiotechnologyHealth Technology Allegro Ophthalmics LLC operates as a biopharmaceutical company. It focuses on the development of novel integrin-regulating therapies for the treatment of ocular diseases. The company was founded by Hampar Karageozian and John Park and is headquartered in San Juan Capistrano, CA. | Health Technology |
- Borsa valori
- Insiders
- Vicken Karageozian
- Esperienza